Brief: Compugroup Medical Outlook FY Revenue EUR 140-160 Million
Sep 07 (Reuters) - Compugroup Medical outlook FY adjusted EBITDA EUR 260-300 million
Recent news on CompuGroup Medical SE & Co KgaA
See all newsBrief: Nagarro to replace CompuGroup in Germany's TecDax, Stratec in SDAX
Brief: Compugroup Medical Delisting Effective 24 June 2025
Brief: Compugroup Medical SE & Co KGaA - Issues Joint Reasoned Statement Recommending Shareholders To Accept Cvc's Public Delisting Offer
Brief: Cvc Capital Partners - Acceptance Period For Public Delisting Offer To Shareholders Of Compugroup Begins
Brief: Caesar Bidco Says Intends To Offer Cash Consideration In Amount Of Eur 22.00 Per CompuGroup Medical Share